Wanfang Natural Medicine

Wanfang Natural Medicine is a Chinese pharmaceutical company specializing in the modernization and commercialization of traditional natural products. Founded in 1994 by Dr. Pan Guofeng, the company is recognized for its expertise in the isolation, purification, and chemical modification of herbal-derived compounds to meet modern clinical standards. Its flagship innovation is Sodium Tanshinone IIA Sulfonate (Nuoxinkang), a widely used injectable drug for cardiovascular conditions derived from Salvia miltiorrhiza. The company operates research facilities in Beijing and manufacturing operations in Yunnan, bridging the gap between botanical medicine and evidence-based pharmaceutical therapy.